Biotech Stocks
An uncertain future for Aurora, the first startup dedicated to custom CRISPR therapies
Endpoints News
4h ago
Aurora Therapeutics, the first company that focused on creating bespoke gene editing treatments, has laid off several staff members and stopped its lead program. The company was using CRISPR base editing to fix mutations that ...
Discussion
Sign in to join the discussion. Comments loading…